Trainee Track Webinar Thursday, April 6, 2017

Trainee Track Webinar
Transplantation and Private Practice: A Career Alternative and its Impact on Academic Recruitment
Thursday, April 6, 11am EST (Montreal time)


  To view the recording of the presentation click here (You must be logged into the website)

Speaker:  

Daniel C. Brennan
Professor of Renal Diseases
Director of Transplant Nephrology
Washington University School of Medicine
St. Louis, Missouri, United States

  Dan Brennan

Moderator:  

Larry Melton
Medical Director of Organ Transplant
Hackensack University Medical Center
Hackensack, New Jersey, United States

  larry melton

Daniel C. Brennan - Biography:

Daniel C. Brennan, MD, FACP, is the Alan A. and Edith L. Wolff Professor of Renal Diseases and the Director of Transplant Nephrology at Washington University School of Medicine in St. Louis, Missouri.  Dr. Brennan’s research interests are viral infections, induction immunosuppression therapy, pharmacoeconomic and outcome research in transplantation and islet transplantation. He has written more than 200 original publications and several textbooks in these areas.


Larry Melton - Biography:

Dr. Melton is the Medical Director of Organ Transplant at HackensackUMC.  He was previously the Medical Director of Kidney/Pancreas transplant at the Simmons Transplant Institute, Baylor University Medical Center in Dallas, TX.  His interests are kidney and pancreas transplantation, combined liver/kidney transplantation and kidney function in liver disease.  He is board certified in Internal Medicine, Nephrology and Critical Care Medicine.  He attended Baylor University followed by graduate work at the University of Texas Health Science Center in Dallas where he earned a PhD in physiology.  He went to medical school at the University of Texas Medical School in San Antonio and did his internship at Parkland Memorial Hospital in Dallas.  He then moved to Boston, MA where he did his nephrology and transplant training at the Beth Israel Hospital and remained on the faculty at Harvard Medical School for a year after completion of his training.  Following that, Dr. Melton took a position in Dallas where he worked with the transplant program at Baylor University Medical Center and was a senior partner and treasurer of Dallas Nephrology Associates.  While in Dallas, he was also a Professor of Internal Medicine at Texas A&M Medical School.  He was President of the Texas Transplantation Society and is active in the American Society of Transplantation.  He has served on the Board of Directors for the AST, as Chair of the Transplant Accreditation Committee, as well as several other committees including the Public Policy Committee.   Dr. Melton  testified before Congress for the AST in support of eliminating the 36 month limit on immunosuppressive medication coverage.  He has participated in multiple clinical research trials, has authored many papers and book chapters and served as the Co-Scientific Editor of Dialysis and Transplantation.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi